News
The company’s custom implants compete with devices from Medtronic, Johnson & Johnson and Globus Medical.
Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.
The defect has resulted in problems including a procedural delay, difficulty removing device fragments and bleeding, the FDA said.
The demonstration of a trans-Atlantic operation using Intuitive Surgical’s da Vinci 5 robot on a tissue model was a focus at ...
The orthopedics firm is looking to round out its robotics offerings with the planned $177 million acquisition. Some analysts ...
The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed ...
Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...
J&J’s electrophysiology group returned to growth in the second quarter after a decline in the prior quarter. Now, can the ...
President Donald Trump unveiled the new duty rates, set to begin Aug. 1, in separate letters shared on social media Saturday ...
The deal allows Zimmer to sell Getinge’s infection control and surgical products alongside its orthopedic implants and robots ...
The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...
Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results